Jiangsu Nhwa Pharmaceutical Co Ltd (002262) — Cash Flow Reinvestment Rate
Jiangsu Nhwa Pharmaceutical Co Ltd (002262) has a Cash Flow Reinvestment Rate of 0.19x as of September 2025, reinvesting CN¥80.95 Million (capex CN¥80.95 Million ) from operating cash flow of CN¥425.83 Million. Check Jiangsu Nhwa Pharmaceutical Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jiangsu Nhwa Pharmaceutical Co Ltd Cash Flow Reinvestment Rate (2005–2025)
Historical reinvestment intensity for Jiangsu Nhwa Pharmaceutical Co Ltd across 21 annual periods. Explore Jiangsu Nhwa Pharmaceutical Co Ltd long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Jiangsu Nhwa Pharmaceutical Co Ltd (2005–2025)
Year-by-year capital reinvestment analysis for Jiangsu Nhwa Pharmaceutical Co Ltd. For live market cap and broader valuation context, see Jiangsu Nhwa Pharmaceutical Co Ltd (002262) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.43x | CN¥458.62 Million | CN¥1.08 Billion | CN¥437.41 Million | ▼ -21.5% |
| 2024 | 0.54x | CN¥496.18 Million | CN¥916.13 Million | CN¥450.06 Million | ▼ -18.2% |
| 2023 | 0.66x | CN¥667.38 Million | CN¥1.01 Billion | CN¥373.99 Million | ▼ -43.9% |
| 2022 | 1.18x | CN¥1.02 Billion | CN¥861.02 Million | CN¥327.75 Million | ▲ +93.6% |
| 2021 | 0.61x | CN¥427.51 Million | CN¥701.12 Million | CN¥206.11 Million | ▼ -19.5% |
| 2020 | 0.76x | CN¥945.61 Million | CN¥1.25 Billion | CN¥268.61 Million | ▼ -54.1% |
| 2019 | 1.65x | CN¥505.30 Million | CN¥305.97 Million | CN¥160.30 Million | ▲ +96.7% |
| 2018 | 0.84x | CN¥339.65 Million | CN¥404.52 Million | CN¥170.70 Million | ▼ -0.6% |
| 2017 | 0.84x | CN¥382.01 Million | CN¥452.35 Million | CN¥166.01 Million | ▼ -31.3% |
| 2016 | 1.23x | CN¥340.68 Million | CN¥277.14 Million | CN¥102.22 Million | ▼ -33.7% |
| 2015 | 1.85x | CN¥378.75 Million | CN¥204.24 Million | CN¥216.63 Million | ▲ +13.6% |
| 2014 | 1.63x | CN¥261.60 Million | CN¥160.24 Million | CN¥261.60 Million | ▲ +206.2% |
| 2013 | 0.53x | CN¥103.63 Million | CN¥194.33 Million | CN¥103.63 Million | ▲ +5.4% |
| 2012 | 0.51x | CN¥78.01 Million | CN¥154.16 Million | CN¥78.01 Million | ▼ -11.2% |
| 2011 | 0.57x | CN¥46.21 Million | CN¥81.08 Million | CN¥46.21 Million | ▼ -58.8% |
| 2010 | 1.38x | CN¥85.57 Million | CN¥61.79 Million | CN¥85.57 Million | ▲ +101.3% |
| 2009 | 0.69x | CN¥42.15 Million | CN¥61.27 Million | CN¥42.15 Million | ▼ -14.5% |
| 2008 | 0.80x | CN¥37.40 Million | CN¥46.50 Million | CN¥37.40 Million | ▼ -6.9% |
| 2007 | 0.86x | CN¥41.96 Million | CN¥48.55 Million | CN¥41.96 Million | ▼ -25.8% |
| 2006 | 1.16x | CN¥36.09 Million | CN¥30.99 Million | CN¥36.09 Million | ▼ -67.8% |
| 2005 | 3.62x | CN¥31.99 Million | CN¥8.84 Million | CN¥31.99 Million | — |